Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02543255
Title Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial)
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

prostate adenocarcinoma

Therapies

Cabazitaxel

Abiraterone + Leuprolide + Prednisone

Pegfilgrastim

Age Groups: adult
Covered Countries CAN


No variant requirements are available.